(Q41226733)

28 September 2017

title

Fulminant sepsis after the successful treatment of Hodgkin's disease (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

28 June 2022

0 references

S. Weitzman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A402071

28 June 2022

A. C. Aisenberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A402071

28 June 2022

language of work or name

English

0 references

publication date

1 January 1977

1 reference

full work available at URL

28 September 2017

https://api.elsevier.com/content/article/PII:0002934377903485?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

https://api.elsevier.com/content/article/PII:0002934377903485?httpAccept=text/plain

28 June 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

American Journal of Medicine

28 June 2022

published in

1 reference

28 September 2017

volume

62

1 reference

28 September 2017

issue

1

1 reference

28 September 2017

page(s)

47-50

1 reference

Report of the Committee on Hodgkin's Disease Staging Classification

28 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

21 April 2023

Malignant lymphoma. 1.

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

21 April 2023

Malignant lymphoma. 2.

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

Abdominal involvement at the onset of Hodgkin's disease.

21 April 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

Combination chemotherapy of Hodgkin's disease.

21 April 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

Improved survival in Hodgkin's disease

21 April 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

21 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission

21 April 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients.

21 April 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

The management of stages I, II, and III Hodgkin's disease with combined radiotherapy and chemotherapy

21 April 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

A combined modality approach to the treatment of Hodgkin's disease.Preliminary results of a prospectively randomized clinical trial

21 April 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

Combination chemotherapy of advanced Hodgkin's disease. A review

21 April 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

Summary of infectious complications occurring in patients with Hodgkin's disease

21 April 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy

21 April 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

Relation Between Splenectomy and Subsequent Infection: A Clinical Study

21 April 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

Hazard of Overwhelming Infection after Splenectomy in Childhood

21 April 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

The syndrome of asplenia, pneumococcal sepsis, and disseminated intravascular coagulation

21 April 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

A critique of the value of laparotomy and splenectomy in the evaluation of patients with Hodgkin's disease

21 April 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

Fatal Hemophilus influenzae Sepsis in an Asymptomatic Splenectomized Hodgkin's Disease Patient

21 April 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

Serious infection after splenectomy for the staging of Hodgkin's disease

21 April 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

Risk of severe infection in patients with Hodgkin's disease or lymphoma after diagnostic laparotomy and splenectomy

21 April 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

Characterization of Postsplenectomy Bacteremia among Patients with and without Lymphoma

21 April 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

Infections in 92 splenectomized patients with Hodgkin's disease. A clinical review

21 April 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(77)90348-5

21 April 2023

Identifiers

1 reference

28 September 2017

1 reference